Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Metascience and Research Integrity

Date Submitted: Jun 9, 2026
Open Peer Review Period: Jun 9, 2026 - Aug 4, 2026
Date Accepted: Oct 2, 2026
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Redundancy in Evidence Synthesis: Overlap, Waste, and Distortion in the Secondary Evidence Ecosystem

Chengxun C, Yao J, Zhou Y

Redundancy in Evidence Synthesis: Overlap, Waste, and Distortion in the Secondary Evidence Ecosystem

J Meta and Res Int 2026;1:e104150

DOI: 10.2196/104150

Redundancy in Evidence Synthesis: Overlap, Waste, and Distortion in the Secondary Evidence Ecosystem

  • Chen Chengxun; 
  • Jianghong Yao; 
  • Yi Zhou

ABSTRACT

Abstract: The proliferation of overlapping and redundant secondary evidence syntheses has emerged as a critical meta-research concern: multiple review teams independently addressing near-identical clinical questions using overlapping sets of primary studies waste finite research resources and risk distorting the perceived weight of clinical evidence. This review develops a three-dimensional analytical framework—spanning methodological origin, execution-level primary study overlap, and systemic proliferation drivers—to characterize the sources, scale, and consequences of redundancy in evidence synthesis, and critically evaluates proposed solutions against their implementation barriers. Drawing on meta-research studies, meta-epidemiological investigations, and policy analyses published between 2018 and 2026, the review integrates empirical findings on primary study overlap quantified through the corrected covered area metric, meta-research on PROSPERO registration duplication, and analyses of the incentive structures that drive redundant synthesis production. The evidence indicates that methodological redundancy originates from inadequate pre-protocol scoping searches and the absence of automated duplicate detection in registration platforms such as PROSPERO, and that meta-epidemiological studies consistently document moderate to high primary study overlap across systematic reviews on the same clinical question, with overlap rates frequently exceeding 20%. The COVID-19 pandemic functioned as a natural experiment demonstrating that, without coordination infrastructure, surge research conditions amplify redundancy dramatically. Downstream consequences include artificial inflation of evidence certainty through pseudo-replication,direct resource waste with estimates that vary widely depending on costing methodology, and erosion of methodological trust in evidence synthesis as a scientific method. Three unresolved challenges that cut across this analysis demand priority attention: establishing consensus on acceptable redundancy thresholds that distinguish warranted replication from wasteful duplication, developing validated and reproducible methods for AI-assisted overlap detection and evidence synthesis automation, and constructing resource-waste estimates grounded in transparent, empirically defensible costing frameworks rather than extrapolation from small convenience samples.


 Citation

Please cite as:

Chengxun C, Yao J, Zhou Y

Redundancy in Evidence Synthesis: Overlap, Waste, and Distortion in the Secondary Evidence Ecosystem

J Meta and Res Int 2026;1:e104150

DOI: 10.2196/104150

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.